Cargando…

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer

Pancreatic cancer (PC) is one of the most common malignant cancers, ranking the seventh highest causes of cancer-related deaths globally. Recently, RNA N6-methyladenosine (m6A) is emerging as one of the most abundant RNA modifications in eukaryote cells, involved in multiple RNA processes including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xiaoge, Lei, Xiangxiang, Guo, Jinhui, Fu, Wen, Sun, Wen, Lu, Qiliang, Su, Wei, Xu, Qiuran, Tu, Kangsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354683/ https://www.ncbi.nlm.nih.gov/pubmed/35936737 http://dx.doi.org/10.3389/fonc.2022.927640

Ejemplares similares

Landscape of N(6)-Methyladenosine Modification Patterns in Human Ameloblastoma
por: Niu, Xing, et al.
Publicado: (2020)

The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development
por: Liu, Shougeng, et al.
Publicado: (2022)

RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
por: Li, Huihuang, et al.
Publicado: (2021)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

Effects of N(6)-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
por: Zhu, Yong-fu, et al.
Publicado: (2022)

The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets
por: Li, Gaofeng, et al.
Publicado: (2022)

Research Progress of DUB Enzyme in Hepatocellular Carcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Case Report: Retroperitoneal Sarcoma in Six Operations: Our Experience in Operative Management of Blood Vessels
por: Guo, Jinhui, et al.
Publicado: (2022)

RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma
por: Pan, Yimin, et al.
Publicado: (2021)

Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review)
por: Lei, Xiangxiang, et al.
Publicado: (2023)

The Interaction Between N(6)-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
por: Yao, Lin, et al.
Publicado: (2022)

UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinoma
por: Fu, Wen, et al.
Publicado: (2023)

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

Emerging role of RNA modification N6-methyladenosine in immune evasion
por: Lou, Xin, et al.
Publicado: (2021)

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
por: Xu, Xiaoxin, et al.
Publicado: (2023)

BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine
por: Qi, Fuming, et al.
Publicado: (2022)

Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration
por: Shu, Liqi, et al.
Publicado: (2021)

N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA
por: Zhang, Zhongyuan, et al.
Publicado: (2021)

N6-Methyladenosine Modification of PTTG3P Contributes to Colorectal Cancer Proliferation via YAP1
por: Zheng, Yang, et al.
Publicado: (2021)

Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers
por: Dai, Xin-Yuan, et al.
Publicado: (2021)

N(6)-Methyladenosine: A Novel RNA Imprint in Human Cancer
por: Yu, Sihui, et al.
Publicado: (2019)

RNA N (6)-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications
por: Dang, Qin, et al.
Publicado: (2021)

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma
por: Qu, Nanfang, et al.
Publicado: (2021)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Detection of N(6)-methyladenosine modification residues (Review)
por: Zhu, Wei, et al.
Publicado: (2019)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

N(6)-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors
por: Zhan, Lei, et al.
Publicado: (2021)

Mechanisms of RNA N(6)-Methyladenosine in Hepatocellular Carcinoma: From the Perspectives of Etiology
por: Lu, Jiahua, et al.
Publicado: (2020)

The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma
por: Yao, Qi, et al.
Publicado: (2021)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases
por: Sikorski, Vilbert, et al.
Publicado: (2022)

N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism
por: Zhang, Haocheng, et al.
Publicado: (2023)

RNA N(6)-methyladenosine modification in cancers: current status and perspectives
por: Deng, Xiaolan, et al.
Publicado: (2018)

Importance of N(6)-methyladenosine RNA modification in lung cancer (Review)
por: Wang, Yueyang, et al.
Publicado: (2021)

Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers
por: Li, Qinghai, et al.
Publicado: (2021)

N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway
por: Tan, Lei, et al.
Publicado: (2021)

N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
por: Zhao, Yibin, et al.
Publicado: (2022)

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
por: Liu, Yong, et al.
Publicado: (2022)

N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma
por: Xu, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i0bntu9hritggoo2acqlikj76l